Skip to content

Home
About Us
- Board of Directors
- Management Team
Technology
News/Resources
Investor Centre
Contacts

ASX Announcements 2007

21 Dec 2007
Completion of Share Purchase Plan
13 Dec 2007
BIT225 Phase I Human Trial Data Presented at International Meeting
23 Nov 2007
November 2007 edition of BITNews
23 Nov 2007
Shareholder Update
20 Nov 2007
Biotron Share Purchase Plan
16 Nov 2007
Biotron Share Purchase Plan – $2.5 Million Underwriting Agreement
6 Nov 2007
Commercial Ready Grant for Clinical Development of HIV/AIDS Drug
30 Oct 2007
Quarterly Report 30 September 2007
5 Oct 2007
Results of Annual General Meeting
5 Oct 2007
Presentation to Annual General Meeting
13 Sep 2007
Annual report for the year ended 30 June 2007
3 Sep 2007
Notice of Annual General Meeting
16 Aug 2007
BIT225 Phase I Clinical Trial Successfully Completed
7 Aug 2007
Response to ASX query
7 Aug 2007
BIT225 Highly Synergistic with Current Anti-Hepatitis C Virus Therapies
30 Jul 2007
Quarterly Report 30 June 2007
25 Jul 2007
HIV Drug Data Presented at International Conference
10 Jul 2007
Expansion of Biotron Antiviral Program to Hepatitis B Virus and Phase I Trial Update
23 Apr 2007
Quarterly Report 31 March 2007
22 Mar 2007
Biotron Begins Phase I Clinical Trial of its HIV Drug BIT225
26 Feb 2007
Half-year report 31 December 2006
9 Feb 2007
Hepatitis C Virus Program Advanced
8 Feb 2007
Presentation of Company Activities
23 Jan 2007
Quarterly Report 31 December 2006
23 Jan 2007
Successful Completion of Preclinical Program for HIV Drug

<<
2024

2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
>>

Investor Centre

Investor Centre

© Biotron Limited 2016 ABN 60 086 399 144 Site updated 29 November 2024 Legal Notices and Privacy